Bayview Physicians Group ACO

ACO Name and Location:

Bayview Physician Services, PC
Previous Names: N/A
3241 Western Branch Blvd.
Chesapeake, Virginia 23321

ACO Primary Contact:

Organizational Information:

Bayview Physicians Services, PC ACO Participants

ACO Participants	ACO Participant in Joint Venture (Y or N)
Bayview Physicians Services, PC	Y

ACO Governing Body:

Last Name	First Name	Title/Position	Member’s Voting Power	Membership Type	ACO Participant Legal Business Name
Centrone	Anthony	Chair	9.09%	ACO Participant Representative	Bayview Physicians Services, PC
Hartz	James	Vice Chair	18.18%	ACO Participant Representative	Bayview Physicians Services, PC
Forman	Jeffrey	Voting Member	9.09%	ACO Participant Representative	Bayview Physicians Services, PC
Hutchinson	Anne	Voting Member	9.09%	ACO Participant Representative	Bayview Physicians Services, PC
Stockman	Lynne	Voting Member	9.09%	ACO Participant Representative	Bayview Physicians Services, PC
Sposato	Joseph	Voting Member	9.09%	ACO Participant Representative	Bayview Physicians Services, PC
Arusi	Eli	Voting Member	9.09%	ACO Participant Representative	Bayview Physicians Services, PC
Oliver	Sandra	Voting Member	9.09%	ACO Participant Representative	Bayview Physicians Services, PC
Lendi	Heather	Voting Member	9.09%	ACO Participant Representative	Bayview Physicians Services, PC
McNamara	Jack	Voting Member	9.09%	Medicare Beneficiary Representative	Bayview Physicians Services, PC

Key ACO Clinical and Administrative Leadership:

Associated Committees and Committee Leaderships:

Types of ACO Participants or Combinations of Participants that Formed the ACO:

• ACO professionals in a group practice arrangement

Shared Savings and Losses:

Amount of Shared Savings/Losses:

• Second Agreement Period
  • Performance Year 2020, $1,005,375
  • Performance Year 2019, $2,293,958
  • Performance Year 2018, $1,478,899
  • Performance Year 2017, $0
• ​First Agreement Period
  • Performance Year 2016, $0
  • Performance Year 2015, $0
  • Performance Year 2014, $0

Shared Savings Distribution

• Second Agreement Period
  • Performance Year 2020
    • Proportion invested in infrastructure: 70%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 0%
  • Performance Year 2019
    • Proportion invested in infrastructure: 70%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 0%
  • Performance Year 2018
    • Proportion invested in infrastructure: 70%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 0%
  • Performance Year 2017
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
• First Agreement Period
  • Performance Year 2016
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2015
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2014
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2020 Quality Performance Results:

ACO #	Measure Name	Rate	ACO Mean
ACO-43	Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))	0.82	0.95
ACO-13	Falls: Screening for Future Fall Risk	93.51	84.97
ACO-14	Preventive Care and Screening: Influenza Immunization	70.08	76.03
ACO-17	Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention	82.05	81.67
ACO-18	Preventive Care and Screening: Screening for Depression and Follow-up Plan	87.52	71.46
ACO-19	Colorectal Cancer Screening	76.62	72.59
ACO-20	Breast Cancer Screening	74.31	74.05
ACO-42	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease	83.31	83.37
ACO-27	Diabetes: Hemoglobin A1c Poor Control (>9%)	12.32	14.7
ACO-28	Controlling High Blood Pressure	73.9	72.87

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

For previous year’s Financial and Quality Performance Results, please visit data.cms.gov.